Cytokinetics, Inc. Company

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases. Cytokinetics is a different kind of company. It is increasingly unusual that an emerging growth biotechnology company would be dedicated to the discovery, development and commercialization of therapeutics. Similarly, it is more and more uncommon for a biopharmaceutical company to leverage their expertise in one area, in our case the cytoskeleton and the biology of muscle function, to tackle the pursuit of new treatments for multiple disease areas. However, the most important distinguishing feature of Cytokinetics is instead found in our commitment to innovation that has translated our focus on the cytoskeleton into a Research and Development pipeline of multiple, first-in-class compounds. All of the programs we are pursuing offer entirely novel therapeutic approaches to severe unmet clinical needs. The reason is simple. Innovative therapeutics are much more likely to bring substantial benefits to patients. That is our goal.
Technology: Personalised Medicine
Industry: P4 Medicine
Headquarters: United States
Founded Date: 1998
Employees Number: 51-100
Funding Status: IPO
Investors Number: 3
Total Funding: $93M
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Equity

Visit Website
medicalaffairs@cytokinetics.com
http://twitter.com/Cytokinetics
Register and Claim Ownership